Glenmark Pharma has announced its results for the quarter ended September 2010. It has reported net profit at Rs 112 crore as against Rs 80.9 crore, a growth of 38.44% on year-on-year basis.
Consolidated net sales rose 23.05% to Rs 741.4 crore from Rs 602.5 crore.
CNBC-TV18 expected net sales at Rs 702 crore and net profit at Rs 102.4 crore.
The company's trailing 12-month (TTM) EPS was at Rs 6.82 per share (June, 2010). The stock's price-to-earnings (P/E) ratio was 46.72. The latest book value of the company is Rs 65.70 per share.
At current value, the price-to-book value of the company was 4.85. The dividend yield of the company was 0.13%.
The stock's price-to-earnings (P/E) ratio stands at 46.92 on (NSE).
Source: www.moneycontrol.com
Thanks,
Gaurav Agarwal
Head Dealer
DENIP Consultants Pvt Ltd
No comments:
Post a Comment